April 21 2021 - Biopharma ramps up lobbying spend as drug pricing legislation nears
Flag link:
Bio­phar­ma ramps up lob­by­ing spend as drug pric­ing leg­is­la­tion nears
Bio­phar­ma ramps up lob­by­ing spend as drug pric­ing leg­is­la­tion nears
Endpoints
drug pricing
lobbying
legislation
GSK
Teva Pharmaceutical
Merck
JNJ
Flag link:
High School Student Calls On Pharmaceutical Industry To Fund The Planting of 1 Million Trees In 5 Years In National Forests To Increase HCP Access
High School Student Calls On Pharmaceutical Industry To Fund The Planting of 1 Million Trees In 5 Years In National Forests To Increase HCP Access
CP WIre
philanthropy
physicians
environmental concerns
Flag link:
Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales
Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales
Endpoints
Roche
earnings
biosimilars
Flag link:
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Fierce Biotech
Roche
antibodies
COVID-19
Flag link:
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Pharmaceutical Business Review
JNJ
vaccines
COVID-19
Europe
blood clots
Flag link:
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Motley Fool
Regeneron
antibodies
COVID-19
Flag link:
FDA of­fers scathing re­view of Emer­gent plan­t's san­i­tary con­di­tions, em­ploy­ee train­ing af­ter halt­ing pro­duc­tion
FDA of­fers scathing re­view of Emer­gent plan­t's san­i­tary con­di­tions, em­ploy­ee train­ing af­ter halt­ing pro­duc­tion
Endpoints
FDA
Emergent BioSolutions
regulatory inspections
drug manufacturing
vaccines
Flag link:
Biogen Reports New Spinraza Data in SMA
Biogen Reports New Spinraza Data in SMA
Global Genes
Biogen
Spinraza
SMA
Flag link:
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
Reuters
COVID-19
vaccines
CDC
Flag link:
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
NIH
NIH
clinical trials
drug repurposing
COVID-19
Flag link:
Regulatory progress for two biotechs stalls as FDA requests more information
Regulatory progress for two biotechs stalls as FDA requests more information
MedCity News
KalVista
Y-mAbs Therapeutics
FDA
KVD824
HAE
Flag link:
AAN 2021 – Helios backs Alnylam’s sunny forecasts
AAN 2021 – Helios backs Alnylam’s sunny forecasts
EP Vantage
Alnylam
AAN
vutrisiran
Onpattro
hATTR amyloidosis
Flag link:
Key Account Manager
Flag link:
Key Account Manager
Flag link:
Key Account Manager
Flag link:
Key Account Manager
Flag link:
Regional Equine Key Account Manager
Flag link:
Territory Manager
Flag link:
Territory Manager
Flag link:

Pages